Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Researchers compared ABT-288 Low Dose, ABT-288 High Dose and placebo to find out how the approaches affected memory, attention and other thinking skills in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimCorrelation of Phenotype, Genotype and Clinical Efficacy/Toxicity of Clozapine Augmented by Atomoxetine for Treatment Refractory Schizophrenia (CAPG Study)
This study ended early.
In IndianapolisResearchers compared iloperidone and Risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
In BeijingResearchers are comparing Bifeprunox, placebo and Quetiapine to find out how the approaches affect psychotic symptoms in people with schizophrenia.
This study ended early.
Multiple locations, including Radnevo
This study has finished and is no longer accepting participants.
In TaipeiThis study evaluates the effectiveness of Lu AF35700 for people with schizophrenia.
This study ended early.
Multiple locations, including San DiegoA Randomized Controlled Trial to Evaluate the Efficacy of Metacognitive Training for Schizophrenia Applied by Mental Health Nurses: Study Protocol
This study has finished and is no longer accepting participants.
In PortalegreEfficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize... Among Patients of Psychiatric Rehabilitation Ward With Diagnosis of Schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedEfficacy of Repyflec Cognitive Remediation Group Training in Cognition, Functional Outcomes and Psychiatric Symptoms of Outpatients With Schizophrenia.
This study has finished and is no longer accepting participants.
In Sant Boi de LlobregatThis study has finished and is no longer accepting participants.
In LyonResearchers compared OPC-34712 and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockThis study evaluated the safety and effectiveness of AVP-786 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.